Urgently Enrolling

Urgently Enrolling

Cutting-Edge Type 1 Diabetes Study

  • This clinical study is exploring whether an investigational study drug can help preserve the body’s ability to make insulin and reduce the need for daily insulin therapy, while keeping blood glucose levels within acceptable limits.

    • Participant must be between the ages of 1 and 25

    • Participant must have received diagnosis of Type One Diabetes very recently*.

    (*within the past 2 months prior to submission)

  • Gain access to cutting-edge medications before they are widely available.

A boy receiving a vaccination from a healthcare professional in a clinical setting.

Think you or your child may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.